- Home
- MKTW vs LTRN Comparison
MKTW vs LTRN Comparison
Compare MKTW & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- LTRN
- Stock Information
- Founded
- MKTW 1999
- LTRN 2013
- Country
- MKTW United States
- LTRN United States
- Employees
- MKTW N/A
- LTRN N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- MKTW Technology
- LTRN Health Care
- Exchange
- MKTW Nasdaq
- LTRN Nasdaq
- Market Cap
- MKTW 46.9M
- LTRN 49.9M
- IPO Year
- MKTW N/A
- LTRN 2020
- Fundamental
- Price
- MKTW $14.48
- LTRN $3.97
- Analyst Decision
- MKTW Hold
- LTRN Strong Buy
- Analyst Count
- MKTW 1
- LTRN 1
- Target Price
- MKTW $20.00
- LTRN $25.00
- AVG Volume (30 Days)
- MKTW 14.1K
- LTRN 178.8K
- Earning Date
- MKTW 11-06-2025
- LTRN 11-06-2025
- Dividend Yield
- MKTW 5.52%
- LTRN N/A
- EPS Growth
- MKTW 59.71
- LTRN N/A
- EPS
- MKTW 2.83
- LTRN N/A
- Revenue
- MKTW $358,121,000.00
- LTRN N/A
- Revenue This Year
- MKTW N/A
- LTRN N/A
- Revenue Next Year
- MKTW N/A
- LTRN N/A
- P/E Ratio
- MKTW $5.11
- LTRN N/A
- Revenue Growth
- MKTW N/A
- LTRN N/A
- 52 Week Low
- MKTW $9.08
- LTRN $2.55
- 52 Week High
- MKTW $21.74
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- MKTW 39.32
- LTRN 41.62
- Support Level
- MKTW $13.50
- LTRN $4.07
- Resistance Level
- MKTW $14.91
- LTRN $4.58
- Average True Range (ATR)
- MKTW 0.57
- LTRN 0.30
- MACD
- MKTW -0.01
- LTRN -0.03
- Stochastic Oscillator
- MKTW 43.35
- LTRN 9.84
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.